HLS Therapeutics Inc (DE:74D)

HLS Therapeutics Inc (74D) Cash flow


HLS Therapeutics Inc Cash Flow

DE:74D's free cash flow for Q4 2023 was $3.72M. For the 2023 fiscal year, DE:74D's free cash flow was decreased by $-1.19M and operating cash flow was $3.73M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 15.79M$ 15.79M$ 16.94M$ 16.43M$ 9.34M$ 26.41M
Investing Cash Flow
$ -189.00K$ -189.00K$ -10.15M$ -4.51M$ -44.68M$ -15.36M
Financing Cash Flow
$ -14.64M$ -14.64M$ -6.86M$ -11.40M$ 9.56M$ 23.95M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 85.38M$ 21.95M$ 20.72M$ 21.18M$ 20.61M$ 47.08M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
Issuance Of Capital Stock
----$ 0.00$ 37.33M
Issuance Of Debt
$ -9.46M$ -9.46M$ -441.00K$ -11.14M$ 20.00M$ 0.00
Repayment Of Debt
$ -9.46M$ -9.46M$ -10.44M$ -11.14M$ -6.66M$ -5.45M
Free Cash Flow
$ 15.60M$ 15.60M$ 16.79M$ 16.43M$ -35.33M$ 11.05M
Domestic Sales
Foreign Sales
Currency in USD

HLS Therapeutics Inc Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis